MAPT and Alzheimer disease: Additionally, immunohistochemical analysis showed reduced expression of amyloid-beta (Aβ40 and Aβ42) in the hippocampus, and Western blotting confirmed a decrease in tau phosphorylation, both of which are downstream consequences of oxidative stress in AD pathology (Ma et al., 2013).